Results 131 to 140 of about 327,270 (275)

Mucosal-Associated Invariant T (MAIT) cells are impaired in Th17 associated primary and secondary immunodeficiencies

open access: yes
The recently described Mucosal Associated Invariant T (MAIT) cells mediate specific recognition of bacterial and fungal vitamin B2 metabolites. As innate T cells, they possess broad effector responses, including IFN- including Iproduction, that are ...
Barcenas-Morales, Gabriela   +8 more
core   +1 more source

Could thymomectomy be a reasonable option for non-myasthenic thymoma patients? [PDF]

open access: hybrid, 2017
Valentina Tassi   +8 more
openalex   +1 more source

Graft‐versus‐host disease‐like erythroderma: a manifestation of thymoma‐associated multiorgan autoimmunity [PDF]

open access: bronze, 2015
Shay Warren   +5 more
openalex   +1 more source

Rare association of thymoma, myasthenia gravis and sarcoidosis : a case report [PDF]

open access: gold, 2008
Mohankumar Kurukumbi   +4 more
openalex   +1 more source

[Thymomas].

open access: yesAnales de medicina interna (Madrid, Spain : 1984), 1991
Thymomas are non-frequent neoplasias which are interesting because of their special association with the immune system pathology; although the pathogenic relationship has yet to be confirmed. A literature review is carried out on clinical aspects, prognosis and treatment, basically chemotherapy in advanced cases.
A B, Sánchez Heras   +3 more
openaire   +1 more source

Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah’s Witness [PDF]

open access: gold, 2019
Maria M. Rubinstein   +5 more
openalex   +1 more source

Germinal centers are associated with postthymectomy myasthenia gravis in patients with thymoma [PDF]

open access: hybrid, 2023
Hye Yoon Chung   +8 more
openalex   +1 more source

VATS thymectomy for early stage thymoma and myasthenia gravis: combined right-sided uniportal and left-sided three-portal approach

open access: hybrid, 2017
Maurizio Infante   +7 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy